Global Transcranial Magnetic Stimulator Market by Application (Epilepsy, Depression), by Type (dTMS, rTMS) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global transcranial magnet stimulator market was worth USD 883.38 millions in 2018. It is expected to grow at an 8.8% CAGR over the forecast period. The growth is driven by the increasing prevalence of neurological disorders such as Alzheimer's (PD) and Parkinson's (PD), as well as increased awareness among professionals about TMS.

Transcranial magnetic stimulation (TMS), a non-invasive treatment, uses a magnetic field to stimulate the brain's nerve cells and reduce chronic pain. It can also help with symptoms of neurological disorders such as depression. TMS is most commonly used to treat Treatment-resistant Depression (TRD). This treatment has been reported by many healthcare professionals to be very effective. Patients with metal implants in their eyes or ears, facial tattoos using magnetic ink or cardiac pacemakers should not undergo this treatment.

Calabasas TMS Center is one of the first TMS treatment centers in America that provides treatment for patients with depression. Healthcare authorities, such as the U.S. FDA, have approved TMS for various disorders--Post-Traumatic Stress Disorder (PTSD), PD, schizophrenia, stroke, nicotine addiction, and chronic pain.

A report from the ScienceDirect shows that 5.8 million Americans were living with Alzheimer's Disease (AD) in 2018. In the United States, an average of 65 people are diagnosed with AD every day. Around 10 million people in Europe are thought to be affected by dementia according to WHO. According to WHO, the number of people with dementia will rise from 50 million in 2018 up to 152 million by 2050. Market growth will be aided by the increasing prevalence of AD and dementia.

According to NCBI, dopamine insufficiency can cause depression, memory loss and loss of balance. It can also lead to stiffness in the muscles. According to the Parkinson's Foundation, approximately 1 million Americans will be diagnosed with PD by 2020. PD is more common in men than it is in women. According to the Anxiety & Depression Association of America (ADA), around 40 million Americans suffer from anxiety disorders. TMS has seen a rise in global demand due to the increasing prevalence of anxiety disorders and PD.

Type Insights

The market for Deep TMS (dTMS), segment, is expected to be the largest in the forecast period. This is due to increasing awareness and the rising incidence of Major Depressive Disorder (MDD). Deep TMS uses magnetic fields to treat scalp conditions. This procedure allows for non-invasive treatment in deep brain areas of patients with neurological disorders such as depression.

As a novel treatment for anxiety and depression, repetitive TMS (rTMS), is expected to grow rapidly. It allows direct stimulation of deeper brain volumes and greater depths (7-10). It is non-invasive and doesn't require any surgery or the implantation of electrodes. It was discovered that rTMS can treat a variety of psychiatric disorders such as schizophrenia, unipolar depression, and bipolar disorder. Market growth will be positively impacted by the recommendations of doctors and the research related to rTMS.

Application Insights

The market's largest share was held by depression in 2018, according to the application. According to WHO, more than half of those diagnosed with depression received treatment in 2018. According to the Mental Health America (MHA), approximately half of the U.S. population suffers from a mental disorder, such as MDD, or other disorders. The large share of this segment can be attributed for the high prevalence of depression around the world.

Epilepsy, a chronic and non-communicable brain disease that affects all ages, is one example. Worldwide, epilepsy affects more than 50 million people according to WHO. Additionally, epilepsy is diagnosed in approximately 2.4 million people each year. In high-income countries, there is an average of 30 to 50 new epilepsy cases per 1 00,000. WHO estimates that the risk of premature deaths in epilepsy patients is three times greater than in the general population in 2019. Market demand is expected to increase due to the increasing prevalence of epilepsy.

Regional Insights

North America is expected be the market leader in transcranial magnet stimulator sales due to its favorable reimbursement policies, increased awareness, the availability of highly-skilled physicians and established healthcare facilities. Further growth is being supported by increasing adoption of technologically advanced products as well as increased funding from the government for research and development in devices & surgical techniques.

Asia Pacific will see the fastest growth rate during the forecast period. This is due to the rising incidence of neurological and physiological disorders, increased government initiatives, as well as the increasing number of awareness programs run by NGOs. The regional market is driven by growing medical tourism, rising incidences of MDD and increased healthcare spending.

Market Share in Transcranial Magnetic Stimulator

Brainsway Ltd., Nexstim Plc, Magstim; Neuronetics Inc.; TMS Neurosolutions and Mag Venture are some of the key players. These companies are focused on the launch of new technologies and growth strategies such as mergers and acquisitions. In September 2017, eNeura Inc. was approved by the FDA for eNeura Spring TMS. This is a device that can be used to treat migraine acutely and prophylactically.

Market Report on Transcranial Magnetic Stimulator (TMS) Scope

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and an analysis of industry trends in each sub-segment from 2015 to 2026. Grand View Research has divided the global transcranial magnet stimulator market report by type, application, region.

• Type Outlook (Revenue USD Million, 2015-2026)

  • Deep Transcranial Magnetic Stimulator

  • Repetitive Transcranial Magnet Stimulator (rTMS).

  • Other

• Application Outlook (Revenue USD Million, 2015-2026)

  • Alzheimer's Disease

  • Depression

  • Parkinson's Disease

  • Epilepsy

  • Other

• Regional Outlook (Revenue USD Million, 2015-2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA).

    • South Africa

    • Saudi Arabia

    • UAE

These are the most frequently asked questions about this report

b. Global transcranial magnetic stimulator (TMS) market was valued at USD 959.0 Million in 2019. It is forecast to grow to USD 1.0 Billion in 2020.

b. Global transcranial magnetic stimulator markets are expected to expand at an 8.8% compound annual growth rate from 2019 to 2026, to reach USD 1.73 Billion by 2026.

b. Repetitive transcranial magnet stimulation (rTMS), dominated the transcranial stimulator market in 2019, with a 38.33% share. This can be attributed to surgeons' increasing preference and the increased use of rTMS.

b. Some of the major players in the transcranial magnet stimulator market are BrainsWay Ltd., Nexstim Plc, Magstim, Neuronetics, Inc., TMS Neuro Solutions, MagVenture, eNeura, Inc.

b. Market growth is driven by technological advances, increased awareness about products, an increasing prevalence of neurological disorders, and increasing incidences of psychological disorders.

Up Market Research published a new report titled “Transcranial Magnetic Stimulator Market research report which is segmented by Application (Epilepsy, Depression), by Type (dTMS, rTMS), By Players/Companies Magstim; Neuronetics, MagVenture, Inc; TMS Neuro Solutions, Nexstim Plc, Inc, BrainsWay Ltd, eNeura”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Transcranial Magnetic Stimulator Market Report Segments:

The market is segmented by Application (Epilepsy, Depression), by Type (dTMS, rTMS).

Transcranial Magnetic Stimulator Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Transcranial Magnetic Stimulator Market

Overview of the regional outlook of the Transcranial Magnetic Stimulator Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Transcranial Magnetic Stimulator Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Transcranial Magnetic Stimulator Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Epilepsy

                2. Depression

                1. dTMS

                2. rTMS

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Transcranial Magnetic Stimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Transcranial Magnetic Stimulator Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.